Overview
What is Access To Advanced Health Institute?
Access to Advanced Health Institute (AAHI) is a nonprofit biotech research institute, headquartered in Seattle, Washington, dedicated to developing vaccines, adjuvants, diagnostics, and drugs for preventing, detecting, and treating infectious diseases of global significance. AAHI's innovative RNA vaccine platform, based on self-amplifying RNA technology and a flexible nanostructured lipid carrier, sets it apart from existing licensed RNA vaccines. This technology could lead to vaccines with extended shelf life, the ability to be stored at room temperature, and faster manufacturing to address future pandemics. AAHI's scientists are currently advancing RNA vaccines against COVID-19, influenza, yellow fever, Zika, chikungunya, and HIV, and are adapting the platform for delivery by nasal spray or direct administration into tumors. Employing 79 dedicated professionals, AAHI's mission is to harness the immune system to alleviate disease and bring accessible, high-quality solutions to the global community.
Official website here: www.aahi.org
Is Access To Advanced Health Institute legitimate?
Access To Advanced Health Institute is a legitimate nonprofit organization registered as a 501(c)(3) entity. Access To Advanced Health Institute submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Here are some key statistics you may want to consider:
Executive Compensation: $3,400,903
Professional Fundraising Fees: $0
Other Salaries and Wages: $4,863,246
For more financial information, click here
Official website here: www.aahi.org
What is the mission statement of Access To Advanced Health Institute?
Access to Advanced Health Institute is a non-profit biotech research institute dedicated to creating accessible, high-quality products and solutions to combat infectious diseases of global significance. The institute brings together leading experts, technologies, and platforms to harness the immune system and alleviate disease. Their focus on RNA vaccines sets them apart, with a self-amplifying RNA technology and nanostructured lipid carrier delivery system. This technology enables the vaccine to be stockpiled for extended periods, delivered at room temperature, and manufactured rapidly for addressing future pandemics. Researchers at the institute are developing RNA vaccines against various diseases, including COVID-19, influenza, yellow fever, Zika, Chikungunya, and HIV, and exploring nasal spray and direct tumor administration as delivery methods.
Official website here: www.aahi.org
Who is the CEO of Access To Advanced Health Institute?
Jerry Kuo is the Ceo, President of Access To Advanced Health Institute. The CEO's salary of Access To Advanced Health Institute is $626,233 and their total compensation is $660,114.
Official website here: www.aahi.org
What is the revenue of Access To Advanced Health Institute?
Access To Advanced Health Institute's revenue in 2022 was $51,186,254.
Official website here: www.aahi.org
Who are the executives of Access To Advanced Health Institute and what are their salaries?
The average compensation at Access To Advanced Health Institute during 2022 was $104,609. There are 79 employees and 5 volunteers at Access To Advanced Health Institute.
Here are 24 key members and their salaries (Access To Advanced Health Institute's CEO's salary is $626,233 and their total compensation is $660,114):
- Corey Casper (Ceo, President) [Trustee/Director]
- Jerry Kuo (Coo & Cfo, Treasurer)
- Candice Decaire (Chief Strategy Officer, Secretary)
- Anna Marie Beckmann (Evp, Product Development)
- Christopher Fox (Senior Vp Of Formulations)
- Linda Hawkins (Dir. Quality Assurance)
- Robrick Smith (Dir. Information Technology)
- Darren Klemkow (Dir. Facilities & Procurement)
- Alan Lew (Senior Clinical Trial Manager)
- Emily Voigt (Principal Scientist)
- Lisa Mcneill (Dir. Manufacturing)
- Jeffrey Guderian (Dir. Laboratory Management)
- Zachary Sagawa (Dir. Clinical Research & Reg. Affairs)
- Harnik Gulati (Dir. Project Management)
- John Argerious (Associate Director, Business Admin)
- Damon Pang (Corporate Counsel)
- Lisa Bouchard (Dir. Quality Control)
- Shelly Crocker (Receiver Thru 02/22) [Trustee/Director]
- Patrick Soon-Shiong (Board Member) [Trustee/Director]
- David Kerr (Board Member) [Trustee/Director]
- Edward Mocarski (Board Member) [Trustee/Director]
- Edward Hsu (Board Member) [Trustee/Director]
- Glenda Gray (Board Member) [Trustee/Director]
- Raoul Concepcion (Board Member) [Trustee/Director]
Official website here: www.aahi.org
Where can I find the form 990 for Access To Advanced Health Institute?
The Access To Advanced Health Institute’s most recent form 990 was submitted in 2022 and can be accessed here
Official website here: www.aahi.org
Learn more at the official website: www.aahi.org
Mission Statement of Access To Advanced Health Institute
Access to Advanced Health Institute (AAHI) is a renowned nonprofit biotech research institute, dedicated to bringing together top experts, technologies, and platforms to develop accessible, high-quality products and solutions for preventing, detecting, and treating infectious diseases of global significance.
At the heart of AAHI's mission lies the creation of vaccines, adjuvants, diagnostics, and drugs to combat infectious diseases. The institute's innovative approach harnesses the power of the immune system to alleviate diseases, focusing on creating accessible and effective solutions for the global community.
AAHI's research is centered around RNA vaccines, which have proven to be crucial tools in combating pandemics and have safely been administered to billions of people worldwide. AAHI's unique RNA vaccine platform, based on self-amplifying RNA technology and delivered by a flexible nanostructured lipid carrier, offers several advantages. The vaccine can be stockpiled for years, delivered at room temperature, and rapidly manufactured to address future pandemics. AAHI's scientists are currently advancing RNA vaccines against various diseases, including COVID-19, influenza, yellow fever, Zika, Chikungunya, and HIV, and exploring the possibility of delivering the platform via nasal spray or directly into tumors.
Impact
This information is meant to be a general summary of Access To Advanced Health Institute. Please take the time to review official sources before making any decisions based upon the content provided here.
Thursday, August 15, 2024
Access To Advanced Health Institute's impact lies in revolutionizing the field of medical research with its groundbreaking work in developing RNA vaccines. These vaccines have proven to be critical tools in combatting pandemics and have been safely administered to billions of people worldwide. AAHI's RNA vaccine platform, based on self-amplifying RNA technology delivered by a flexible nanostructured lipid carrier, offers unique advantages. It enables stockpiling for years, room temperature storage, and rapid manufacturing capabilities to address future pandemics effectively.
The institute's dedicated scientists are advancing RNA vaccines against various infectious diseases like COVID-19, influenza, yellow fever, Zika, chikungunya, and HIV. They are also adapting the platform for delivery via nasal spray or direct administration into tumors, showcasing the versatility and potential of this innovative technology. AAHI's commitment to harnessing the immune system to alleviate diseases underscores its mission to create accessible, high-quality products and solutions for global health challenges.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2022.
- Assets and Liabilities:
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
SERVICES AND CONTRACTS
Revenue
$12,694,920
LICENSING
Revenue
$4,691,574
Organization Details
Founding Year
1993
Phone
(206) 381-0883
Principal Officer
Jerry Kuo
Main Address
1616 EASTLAKE AVE E 400, SEATTLE, WA, 98102
Website
www.aahi.org
NTEE Category
Code: H90 - Medical research
If you are a representative of Access To Advanced Health Institute and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.